maps • volume xiv number 2 • rites of passage: kids and psychedelics 2004
Introduction, Sylvia Thyssen

We are very far
from the picture
Aldous Huxley painted
of Pala in Island,
where young adults
use a psychedelic
"moksha medicine"
as part of a
rite-of-passage
into adulthood.
FOR A WEEK EACH MONTH, I am buffeted by emotional storms from the hormonal fluctuations that many young women experience. Those days sometimes remind me of the sense of isolation and gloom I felt most acutely as a teenager, and the alienation I perceived between myself and other people, especially my parents. I wasn't much of an experimenter--I tried pot once when I was 16, and it just made me feel mildly anxious. It didn't occur to me to try it again, although some of my favorite friends were stoners. In retrospect, it's easy to imagine that a well-planned, therapeutic MDMA experience might have provided a powerful sense of equanimity and self-acceptance that I desperately needed. Yet most of my peers and I had no reference point, social milieu, or familial context that would admit a balanced, intentional use of MDMA or other psychedelics.

The issue is complex. After we settled on "Kids and Psychedelics" as a topic for the Bulletin, we repeatedly got feedback that this button was too hot to touch. Frequently when activities involving minors were discussed, people expressed their fears of criminal liability or extreme public disapproval. It has been striking to me that this topic is taboo among some of those who openly discuss the adult use of psyche- delics. Perhaps these people are con- cerned that even talking about the issue could bring more negative attention onto the psychedelic community.

We are very far from the picture Aldous Huxley painted of Pala in Island, where young adults use a psychedelic "moksha medicine" as part of a rite-of-passage into adulthood. Even though we are aware of some traditional cultures' initiatory ceremonies, it can be difficult or of limited relevance to try to integrate these practices into our own lives. Most youthful experimentation with psychedelics (usually beginning with Cannabis) is done among peers, with little formal ritual. Some of these minors--often independently of family, but sometimes within a supportive family context--have experiences with psychedelics that contribute to their growth and their knowledge of the world. This idea is vigorously condemned and feared by many adults who can't handle the complexity surrounding the human motivation for using psychoactives. It can be hard to talk about without getting mired in discussions of failed drug policies and the ongoing damage that the Drug War inflicts on teen culture. There are many open questions about how to reduce underinformed, impulsive use and help kids to make healthier choices. For this reason we've included several articles that discuss drug education and touch on the problems faced when trying to direct youth to act wisely and with restraint.

This issue doesn't include much about the potentially harmful, addictive, and sometimes life-threatening experiences that can result from reckless use. However, it is important to note that confronting fear is often a valuable aspect of psychological and spiritual transformation, and a symbolic death experience is part of some rites-of-passage ceremonies. Although the darker side of psyche- delic use is not featured in this issue, it nevertheless deeply informs my reasons for focusing on the positive. I am inspired by people like Becca (see pages 39­44) who generally use good sense, healthy curiosity, and an increasingly comprehensive set of informational resources to make thoughtful decisions about what they consume. And I am equally alarmed by the "under-intentional" use of psychedelics by some kids. However, if as adults we can't offer a vision for that which is possible and beneficial, what kind of role models are we?

From the vantage point of a former neophobe, I have heard and read the stories we have collected with a sense of wonder. Through my professional work, I contribute to the growing body of information about psychoactives. I'm not a parent, educator, guidance counselor, or mentor for any teens. I simply have concern and compassion for their experiences growing up in an often scary and confusing world. I think of how in the film Bowling for Columbine, director Michael Moore asks Marilyn Manson, a favorite musician of some disenchanted teens, what he would tell the kids and community of Columbine, Colorado who witnessed the tragic 1999 school massacre. Manson replies, "I wouldn't say a single word to them. I would listen to what they have to say." Perhaps what we need to do most of all to help kids form reasonable and healthy relationships with psychedelics is to talk less and listen more.

-- Sylvia Thyssen, Editor

Summer 2009 Vol. 19, No. 2 MAPS Research Update 2009
Spring 2009 Vol. 19, No. 1 Special Edition: Psychedelics and Ecology
Winter 2008/09 Vol. 18, No. 3 MAPS 2008 Financial Report
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Spring 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine